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The frequency of ADHD in the aging population and its relationship to late-life cognitive decline has not been studied previously.
To address this gap in our understanding, the Wender-Utah ADHD Rating scale (WURS) was administered to 310 geriatric
subjects with cognitive status ranging from normal cognition to mild cognitive impairment to overt dementia. The frequency
of WURS-positive ADHD in this sample was 4.4%. WURS scores were not related to cognitive diagnoses, but did show nonlinear
associations with tasks requiring sustained attention. The frequency of ADHD appears stable across generations and does not
appear to be associated with MCI or dementia diagnoses. The association of attentional processing deficits and WURS scores
in geriatric subjects could suggest that such traits remain stable throughout life. Caution should be considered when interpreting
cognitive test profiles in the aging population that exhibit signs and symptoms of ADHD, as attentional deficits may not necessarily
imply the existence of an underlying neurodegenerative disease state.

1. Introduction
Attention-deficit hyperactivity disorder (ADHD) is a common learning disability in children [1–7]. Symptoms of
ADHD include inattention, hyperactivity, and impulsivity
[2, 5]. About 1–9.5% of children are estimated to suﬀer
from ADHD [1–3, 5, 8, 9]. Previous studies have suggested
that ADHD is increasing in the United States [2, 9]. Factors
including increased television and video game use and a diet
defined by excessive sugar, high-fructose corn syrup, and preservatives have all been implicated as possible mechanisms
leading to ADHD [4, 10–12]. Genetic predisposition to
ADHD has also been suggested by several groups and could
play a role beyond that of environmental factors in the development of ADHD [13–18].
The long-term consequences of ADHD in the geriatric
population and the possible association of ADHD with cognitive decline in older adults are unknown. ADHD persisting

into adulthood has been well documented [6, 8, 19–27].
It is possible that early learning disabilities could influence
later life cognitive function and be associated with latelife neurocognitive disorders such as Alzheimer’s disease
[28]. In fact, individuals with a history of ADHD have a
higher prevalence of comorbid psychiatric disorders such as
antisocial disorders, mood and anxiety disorders, and substance abuse disorders when they reach adulthood [20, 25].
Such comorbidity could contribute to cognitive dysfunction
in older adults meeting diagnostic criteria for mild cognitive
impairment (MCI), Alzheimer’s disease (AD), and other
forms of dementia. Indeed, cognitive dysfunction in adults
with a diagnosis of ADHD in childhood has been reported
by many groups [29–31]. As AD aﬀects over 5 million Americans and is the most common neurodegenerative disease in
the world [32], it is important to understand the full
spectrum of possible risk factors for this devastating disease.
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ADHD has not previously been studied as a risk factor for or
associated feature of sporadic AD in the geriatric population.
The current study plans to address the gap in knowledge
about both the prevalence of childhood ADHD in the geriatric population and the association between ADHD and
late life cognitive functioning. We hypothesize that the prevalence of childhood ADHD will be increased in the subset of
older adults experiencing late-life cognitive decline manifest
as the development of MCI or AD. To test this hypothesis,
we used the Wender-Utah Rating Scale (WURS) [33] to
retrospectively identify possible cases of childhood ADHD in
310 elderly participants with either a cognitive diagnosis of
normal, MCI, mild Alzheimer’s disease, or other dementia.

2. Method
2.1. Subjects. Study participants were drawn from the University of Kentucky Alzheimer’s Disease Center longitudinal
research program. They were predominantly Caucasian and
between the ages of 62 and 91 years old (Table 1). Cohort
participants had detailed cognitive function testing annually
and had neurologic and physical examinations biannually or
annually. Individuals with a history of substance abuse
(including alcohol); major head injury; major psychiatric
illness; medical illnesses that are nonstable, impairing, or that
have an eﬀect on the CNS; chronic infectious diseases; stroke
or TIA; encephalitis; meningitis; or epilepsy are not recruited
into the cohort. The mental status testing of our subjects
has been described previously [34]. Diagnosis was determined by consensus agreement of a panel including the examining neurologist, neuropsychologist, social worker, and
other support staﬀ. This study was approved by the University of Kentucky, College of Medicine Institutional Review
Board.
2.2. Neuropsychological and Rating Scale Assessments. The
Wender-Utah ADHD scale [33] uses 25 characteristics of
ADHD to retrospectively identify suspected cases of childhood ADHD. Participants were asked to consider each question independently and rate how often they experienced
the problems on a Likert-type scale scored from 0 (not at
all/slightly) to 4 (very much). The total was calculated and
a positive diagnosis for presumptive ADHD was assessed at
a score of 36 or above that has previously shown to be a
reliable estimate for ADHD tendencies and possible DSM-IV
diagnosis [33]. Those subjects with a diagnosis of MCI or AD
were also provided a second survey for their informant/study
partner to complete for response comparison. Subject and
informant completed survey results were significantly but
only moderately correlated (r = 0.37, P = 0.0027, Spearman
correlation). To maintain uniformity in data collection and
analysis between all subjects, irrespective of cognitive status,
only subject responses were used for the overall data analysis.
Substitution of informant versus subject responses did not
change the results of the statistical associations or models
presented below.
Neuropsychological test variables used in the present
analyses include Mini-Mental State Examination (MMSE)
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[35], Clinical Dementia Rating scale global & sum of boxes
scores [36], Category Fluency (animal naming), Trailmaking
tests A & B, WAIS Digit-Symbol substitution, Wechsler Logical Memory delayed recall, and the Wechsler Adult Intelligence Scale-revised (WAIS-R) forward and reverse digit span
tests. Only scores from the last evaluation prior to implementation and collection of WURS scores were used in the
present analysis.
2.3. Statistical Analysis. Standard comparative statistics were
used to analyze the data including Chi-square for nominal
data, t-tests (Student’s or Satterthwaite’s as appropriate) for
continuous variables, and Mann-Whitney U-tests for ordinal
variables. Performance on neuropsychological tests was compared using multiple linear regression modeling where the
test score was the dependent variable, and age, sex, education, cognitive status (normal versus not normal), and
ADHD status (WURS-positive versus WURS-negative) were
independent variables. The level for statistical significance
was set at P < 0.02 to reduce the likelihood of Type I error
given the multiple comparisons made in Tables 1–3; however,
the level for statistical significance was retained at P < 0.05
in the exploratory analysis of nonlinear modeling of the
association of animal fluency, WAIS digit span forward, and
WURS scores presented in Figure 1. LOESS plots were created as linear regressions with PROC SGPLOT in SAS 9.2.
PROC SGPLOT determined the optimal smoothing parameter. For the Animals plot, the smoothing parameter was
0.936. For the Digit Forward plot, the smoothing parameter
was 0.335.

3. Results
The WURS was mailed to 687 subjects spanning the cognitive
continuum and 320 of these (46.6%) responded. A small
number (n = 10) of the respondents returned only partially
completed surveys that precluded formal analysis, resulting
in a total sample of n = 310 used in the present analysis.
Subjects who did not respond were similar in age and gender
to responders but were less educated (16.4 ± 3.4 years versus
14.4 ± 2.6 years, Satterthwaite’s t-test, 648.1 d.f., P < 0.0001).
There was a higher proportion of cognitively impaired subjects (i.e., consensus diagnosis was not “Normal”) among
those who did not respond as might be expected (χ 2 = 88.1,
1 d.f., P < 0.0001). The cognitively impaired subjects studied
included 42 with MCI (18 non-amnestic and 24 amnestic
presentations), 6 who were cognitively impaired but failed to
meet current consensus criteria for MCI, and 19 demented
subjects.
Demographic variables between WURS categories (≥36,
<36) are shown in Table 1. A presumptive diagnosis of
ADHD (as assessed by the WURS) was found in 10 cognitively normal and 3 cognitively impaired subjects (4.4% of
the total respondents). The groups did not significantly diﬀer
on age, sex, years of education, or cognitive diagnosis.
Using standard parametric and nonparametric comparative techniques, WURS-positive, presumptive-ADHD
participants did not diﬀer significantly from non-ADHD
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Table 1: Demographic and clinical variables in presumptive positive and negative childhood ADHD subjects as determined by Wender-Utah
Rating Scale score.
Parameter
Age (mean years ± SD)
Gender (M : F)
Cognitive status (Normal : Impaired)
Education (mean ± SD)
CDR Sum of boxes (median)
Normal cognition
Impaired cognition
CDR Global score (median)
Normal cognition
Impaired cognition
†

ADHD positive (n = 13)
74.3 ± 7.4
5:8
10 : 3
15.7 ± 3.3

ADHD negative (n = 297)
77.9 ± 7.5
103 : 194
233 : 64
16.5 ± 2.6

P value
0.09†
0.78‡
0.90‡
0.31†

0.0
3.5

0.0
0.5

0.20§
0.03§

0.0
1.0

0.0
0.5

0.28§
0.37§

Student’s t-test, 308 d.f.; ‡ χ 2 test, 1 d.f.; § Mann-Whitney U-test.

Table 2: Mean neuropsychological test scores (±SEM) adjusted for age, sex, education, and cognitive status in presumptive positive and
negative childhood ADHD subjects as determined by Wender-Utah Rating Scale score.
Neuropsychological test scores
Folstein MMSE
Animal Fluency
Trailmaking test A
Trailmaking test B
WAIS-R Digit-Symbol Substitution
WMS Logical Memory Delayed
WAIS-R Digit Span Forward
WAIS-R Digit Span Backward

ADHD positive (n = 13)
27.5 ± 0.6
15.8 ± 1.4
45.8 ± 4.7
117.7 ± 12.2
38.9 ± 2.8
10.0 ± 1.1
8.5 ± 0.5
6.5 ± 0.6

ADHD negative (n = 297)
27.6 ± 0.2
18.7 ± 0.4
46.2 ± 1.2
110.3 ± 3.1
42.2 ± 0.7
10.0 ± 0.3
9.2 ± 0.1
6.8 ± 0.2

P value
0.84
0.055
0.93
0.55
0.25
0.94
0.14
0.55

Abbreviations: MMSE: Mini-Mental State Examination; CDR: Clinical Dementia Rating scale; WAIS-R: Wechsler Adult Intelligence Scale-Revised; WMS:
Wechsler Memory Scale.

participants on any of the neuropsychological measures
when the means were adjusted for age, sex, education, and
cognitive status (Table 2). These results remained consistent
when only the data from cognitively normal subjects were
considered (Table 3).
These data demonstrated trends for associations with
the animal fluency task and WAIS digit span forward that
prompted further analysis. Scatter plots with LOESS smooths
were constructed to test the assumption of a linear versus
nonlinear relationship between WURS scores and performance on neuropsychological test measure performance, and
the results were suggestive of a nonlinear relationship on
several of the measures (Figure 1). Regression models for
the normals only, using WURS score as a quadratic term,
demonstrate that the WURS-squared was a significant predictor of performance on animal naming (P = 0.030) and
WAIS digit span forward (0.037) even after controlling for
age and education (gender proved not to be significant in
these models, data not shown). The relationship of WURS
scores with WAIS digit span backward was not significant
(P = 0.36) but appeared to have a similar association with
WURS scores. To further assess the dependence of the findings on the use of psychotropic medications, we constructed
a dichotomous variable based on the use of antidepressants,
antipsychotics, mood stabilizers, or stimulants and entered it
as a covariate in the model. The results remained unchanged
from that described above.

4. Discussion
This is the first study to estimate the prevalence of presumptive-ADHD in the geriatric population in the United States.
The present results demonstrate that the frequency of ADHD
tendency as assessed by the WURS is relatively stable across
generations, even in the geriatric population. The prevalence of ADHD in children and adolescents is currently
estimated at 3–9.5% [1, 3, 5, 9], while previous studies have
demonstrated a potentially lower prevalence in middle-aged
adults at 1–6% [22, 23, 27]. Our estimate of 4.4% lies well
within the span of these ranges. The popular belief that
ADHD is increasing could be due to a surveillance bias or to
the increased development and utilization of screening tests
such as the WURS in younger populations [8].
We did not find evidence of an increased frequency
of WURS-positive, presumptive-ADHD in cognitively impaired individuals compared to cognitively normal controls,
despite previous reports of an association with the diagnoses
of MCI and early Alzheimer’s disease in Down syndrome
patients [28]. It is possible that this exploratory analysis
failed to find a diﬀerence due to the low sample size in the
cognitively impaired subjects studied. Further analysis of
association of amnestic and nonamnestic presentations and
WURS-positive ADHD symptoms are again precluded by the
low number of subjects with WURS-positive ADHD in the
sample, but should prove fertile ground for future research
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Table 3: Mean neuropsychological test scores (±SEM) in cognitively intact subjects only, adjusted for age, sex, and education in presumptive
positive and negative childhood ADHD subjects as determined by Wender-Utah Rating Scale score.
ADHD positive (n = 10)
29.3 ± 0.3
18.2 ± 1.6
34.3 ± 3.4
82.8 ± 8.5
45.1 ± 3.0
13.8 ± 1.2
8.5 ± 0.6
7.2 ± 0.6

Neuropsychological test scores
Folstein MMSE
Animal Fluency
Trailmaking test A
Trailmaking test B
WAIS-R Digit-Symbol Substitution
WMS Logical Memory Delayed
WAIS-R Digit Span Forward
WAIS-R Digit Span Backward

ADHD negative (n = 233)
29.2 ± 0.1
20.9 ± 0.4
35.4 ± 0.8
80.5 ± 1.9
46.8 ± 0.7
14.0 ± 0.3
9.6 ± 0.1
7.5 ± 0.1

P value
0.64
0.10
0.74
0.79
0.58
0.90
0.07
0.61

Abbreviations: MMSE: Mini-Mental State Examination; CDR: Clinical Dementia Rating scale; WAIS-R: Wechsler Adult Intelligence Scale-Revised; WMS:
Wechsler Memory Scale.
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Figure 1: Scatterplots of (a) animal naming total words (P = 0.030) and (b) WAIS digit span total length (P = 0.037) versus WURS scores
with LOESS fit using WURS scores squared as a quadratic term after adjustment for age and education. Data presented is for cognitively
normal subjects only.

endeavors. One recent study from Argentina examined the
Spanish WURS in normal elderly, AD, and dementia with
Lewy bodies (DLB), demonstrating an association of higher
WURS scores with DLB, but not AD [37]. A relatively high
frequency of WURS-positive normal controls (15.1%) calls
this data into question and remains unexplained by the authors. Another study found increased tendencies for ADHD
behaviors in adults with Down syndrome presenting with
mild cognitive impairment or early Alzheimer’s disease [28].
This study however did not include analysis of sporadic AD
or the genetically normal geriatric population that is the
focus of the present study. Definitive evidence of an association between childhood ADHD and the late life degenerative
dementia is clearly lacking. An important caveat is that the
lack of an association in the present study is based on purely
cross sectional prevalence data, and so it is still possible that
longitudinal analysis over time will show associations with
the development of incident cognitive impairment. Such
analyses from this and other cohorts will be important contributions to the literature in the future.

While the present data failed to demonstrate an association between WURS-positive, presumptive ADHD, and
clinical diagnoses of MCI or dementia, they do demonstrate
significant associations between tasks requiring sustained attention (Category Fluency and WAIS digit span tests; while
category fluency is primarily a test of language fluency, normative performance is dependent on sustained attention to
the task in addition to language function) and WURS scores
in the normal elderly subjects studied. These results suggest
that ADHD tendencies may represent lifelong cognitive profiles rather than transient early childhood and adolescent
cognitive phenotypes. This interpretation is consistent with
other studies that have demonstrated the persistence of
ADHD tendencies into adulthood for many [22, 24, 25, 27].
It is also plausible that these findings represent a confound
of recall bias where symptoms attributed to childhood performance are actually more representative of temporally
proximate cognitive weaknesses. It should also be noted that
only a subset of cognitive test scores were related to WURS
scores, suggesting that cognitive deficits related to ADHD
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tendencies in the elderly may be restricted to specific cognitive domains or cognitive test paradigms and do not represent evidence for global cognitive decline necessary for a
diagnosis of dementia using existing criteria.
The weaknesses of the present study include the eﬀects
of recall bias (potentially augmented by memory decline in
the cognitively impaired subjects). Despite an awareness that
amnestic symptoms are largely confined to short-term memory mechanisms in MCI and early-stage dementia (with
relative sparing of long-term memories from childhood and
early adult life) [38], it is quite possible that the reduced
frequency of WURS-positive, presumptive-ADHD subjects
in the impaired categories reflects early involvement of longterm in addition to short-term memory retrieval processes.
The present study sought to overcome this confound by
sampling both subject and informant data on all cognitively
impaired subjects. Subject versus informant reports were
significantly correlated, albeit with a moderate coeﬃcient
value. This was not unexpected in the 57 informants who
responded who were mostly adult children and spouses of
the participants and so did not actually know the subject
personally during the early childhood and adolescent years.
Thus, their responses on the WURS may well have been
biased by the subjects’ cognitive characteristics during early
or middle-aged years or through second-hand information
from the subjects themselves in years past. Despite these
caveats, the finding of a positive association between subject
and informant reports lends credence to the present use of
subject reports on the WURS scores used as the basis for this
analysis.
Weaknesses of the present study also include a potential
for limited generalizability of the results. The UK ADC longitudinal cohort is largely Caucasian, highly educated and
excludes participants with history of substance abuse and
major psychiatric disorders (all factors that may lead to an
underrepresentation of ADHD in the sample studied). A
selection bias that may have underrepresented ADHD subjects cannot be excluded. Additional studies of ADHD tendencies using subjects with lower education levels and from
other racial and ethnic backgrounds are needed to further
validate and support any contention of generalizability in
the present results. The lack of validation of the WURS
with formal DSM-IV diagnoses of ADHD represents another
weakness of the present study. Several previous studies have
suggested high diagnostic accuracy (82–99%), sensitivity
(85–91%), and specificity (76–91%) of the WURS for the
diagnosis of ADHD (confirmed by DSM-IV and or ICD-9
criteria) [33, 39–41]; however, other studies have suggested
poor diagnostic accuracy in control subjects seeking evaluation for ADHD (57.5% of the non-ADHD cases studied) and
in control subjects with psychiatric diagnoses of depression
(66–81%) or bipolar disorder (64%) [39, 41, 42]. These
data suggest that the validity of the WURS is dependent
on not only the presence of ADHD, but also other aﬀective
disorders. Exclusion criteria for the present group of subjects
studied include the presence of any DSM-IV psychiatric
diagnosis other than dementia, minimizing this confound,
however, it is still possible that the frequency of WURSpositive, presumptive ADHD in this sample may have been
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inflated by the development of subclinical or undetected affective disorders in our population. Further studies in the
geriatric population, with and without coexistent cognitive
decline, will need to be validated against accepted DSM and
ICD criteria.
The strengths of this study include the use of a clinically well-characterized, longitudinally followed cohort with
extensive neuropsychological, neurological, and medical information readily available for analysis. All subjects in this
cohort have also agreed to undergo autopsy and brain donation at death providing an additional opportunity in the
future to study the potential pathological substrate(s) of
ADHD tendencies. An additional strength of this study lies
in its use of the previously validated WURS. Despite our use
of a group of subjects older by several decades than those
that served to previously validate the WURS, we did not
encounter any diﬃculties when testing our cohort.
In summary, the present data represents a significant
contribution to the field of aging research, representing the
first such study of ADHD tendencies in the geriatric population and the association of childhood ADHD tendencies
with late-life neurodegenerative cognitive impairment in the
United States. These data suggest that (1) the frequency of
WURS-positive, presumptive-ADHD appears stable across
generations, (2) presumptive-ADHD is not associated with
the diagnoses of MCI or dementia, and (3) the finding of
deficits in attentional processing in presumptive-ADHD
subjects in their geriatric years suggests that such traits are
stable throughout life and need to be considered when interpreting cognitive test profiles in the elderly. Further studies in
larger, more diverse populations are clearly needed to refine
our understanding of the associations of ADHD with MCI or
dementia diagnoses and the possible role childhood ADHD
may play in the development of late-life cognitive decline.
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